Clinical and Translational Science

Aims & Scope

Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease.

Translational medicine is a multi-faceted discipline with a focus on translational therapeutics.

In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum.

Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials.

CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine.

Best-in-class methodologies and best practices are also welcomed as Tutorials.

These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science.

CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• PubMed
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine, Neuroscience and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Medicine, Neuroscience and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,460.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Precision Medicine, AI, and the Future of Personalized Health Care

  Citation: 1188

  Authors: Kevin B., Wei‐Qi, Dilhan, Mark E., Karl, Kyu, Juan, Jane L.

• Recommendations for Planning Pilot Studies in Clinical and Translational Research

  Citation: 500

  Authors: Charity G., Rickey E., Paul J., Paul W.

• Standardizing <i><scp>CYP</scp>2D6</i> Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

  Citation: 429

  Authors: Kelly E., Katrin, Michelle, Jesse J., Cyrine E., Teri E., Roseann S., Mary V., Stuart A., Daniel L., Henk‐Jan, Andrea

• Big Data and Large Sample Size: A Cautionary Note on the Potential for Bias

  Citation: 311

  Authors: Robert M., David A., Russell E.

• COVID‐19 vaccine hesitancy: Race/ethnicity, trust, and fear

  Citation: 310

  Authors: Don E., Jennifer A., Keneshia, James P., Christopher R., Holly C., Geoffrey M., Pearl A.

• Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans

  Citation: 285

  Authors: Vishal S., Sushrut S., Michael A., Fitz B., Kelsey, Costas, Gary, Roland, Rebecca A., Gary C., Joseph V.

• Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes

  Citation: 250

  Authors: Jeffrey

• Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes

  Citation: 247

  Authors: Allison B., Robert, Waleed, Dongsheng, Elizabeth, Jongsoon, Steven E.

• Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19

  Citation: 246

  Authors: Yaqing, Tao, Jiaxin, Can, Lei, Shu, Yi, Sheng, Yanjun, Jinxia, Chenhui, Jing, Qiaowei, Xiangrong, Jinhai, Liansheng, Quan, Enzhi

• Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development

  Citation: 231

  Authors: Meric, Kedan